Research into medicinal cannabis, cannabinoids, and healthcare outcomes continues to evolve through ongoing scientific investigation and practitioner-led discussion.
Medicinal cannabis is a prescription-only medicine in Australia and access pathways involve assessment by an appropriately qualified healthcare practitioner operating within Australian regulatory frameworks.
Patients seeking broader educational information may also review what are cannabinoids and what is CBD and an overview of medical cannabis in Australia.
Healthcare practitioners consider a wide range of factors when assessing suitability for any prescribed medication.
Assessment considerations may include:
healthcare history
current medications
previous treatment experiences
individual risk factors
ongoing monitoring requirements
These assessments help support informed clinical decision-making and appropriate healthcare management.
Patients interested in consultation pathways may also review accessing medical cannabis made easy with MOCA Health and how to obtain your medical prescription in Australia.
Cannabinoids remain an active area of scientific and clinical investigation.
Research commonly explores:
biological signalling systems
cannabinoid receptor activity
healthcare outcomes
patient-reported experiences
long-term safety considerations
Researchers continue to examine how cannabinoids interact with the body's natural communication systems, including the endocannabinoid system.
Additional educational information can be found in the endocannabinoid system and the entourage effect.
Where medicinal cannabis forms part of a healthcare management plan, practitioners may discuss:
treatment goals
medication reviews
monitoring processes
follow-up consultations
healthcare communication pathways
Healthcare decisions remain the responsibility of the treating practitioner and are made according to individual circumstances.
Patients seeking information regarding consultation pathways may also review what is tele-health and how does it work and access medical cannabis from anywhere in Australia.
Further educational resources include:
This website provides educational information only and does not constitute medical advice.
Patients seeking information regarding consultation pathways may speak with an appropriately qualified healthcare practitioner.